Contraceptive Technology Update – September 1, 2003
September 1, 2003
View Issues
-
More women know about emergency contraception, but can they get it?
The word is getting out about emergency contraception (EC). A just-released national survey reports that two-thirds of women ages 18-44 are aware that there is something a woman can do to prevent pregnancy in the few days following sexual intercourse. -
Check Nortrel stock — Barr Labs issues recall
If you have any patients who use 28-day packages of Nortrel 7/7/7 oral contraceptives (OCs), be sure your clinic has initiated its patient notification plan following the July 9, 2003, voluntary recall issued by the pills manufacturer, Barr Laboratories of Pomona, NY. -
Low-dose OCs not linked with stroke risk
Findings from a new Australian study indicate that use of modern, low-dose oral contraceptives (OCs) containing 50 mcg estrogen or less do not appear to appreciably raise the risk of ischemic stroke in healthy women. -
New reports spark more questions on HT risks
Just-published papers in the Journal of the American Medical Association add to heightened concern regarding hormone therapy (HT). -
Diabetics present contraceptive dilemma
The next patient in your exam room is a 32-year-old woman with type 2 (adult onset) diabetes. While she is obese, she does not smoke, and her chart shows no evidence of hypertension, nephropathy, or retinopathy. What birth control options can you offer her? -
CTU Updates
New video reviews teen birth control options; NAMS issues revised menopause guidelines